ArticleBMC microbiology2025
Antimicrobial activity and possible mechanisms of juglone against Escherichia coli, Staphylococcus aureus, and Salmonella pullorum.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Performance of Juglone as a Natural Extract for Inhibiting SRB-Induced Corrosion of Q235 Steel in Seawater.Microorganisms · 2026Article
- The antifungal activity and mechanism of action of limonene against tobacco-isolatedFrontiers in plant science · 2026Article
- Optimization of extraction conditions for total flavonoids fromFrontiers in microbiology · 2026Article
- Transcriptomic and metabolomic insights into the antimicrobial mechanisms ofFrontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEscherichia coli, Staphylococcus aureus, and Salmonella pullorum are significant pathogens that threaten livestock and poultry health. Although antibiotics and synthetic antimicrobial agents can combat these pathogens, antibiotic resistance remains a major concern. Recent decades have seen growing interest in antibiotic alternatives. Juglone, a natural naphthoquinone compound from Juglandaceae plant, exhibits strong antimicrobial activity against S. aureus. However, its antimicrobial mechanism is not yet fully understood. This study investigated the antimicrobial mechanism of juglone from the perspectives of cell biology, cell morphology, and transcriptomics.
resultsJuglone had potent antimicrobial effects against E. coli, S. aureus, and S. pullorum. The minimum inhibitory concentration (MIC) of juglone against all three bacterial strains was 15.6 µg/mL. Treatment with juglone decreased bacterial metabolic activity, reduced the intracellular DNA and RNA fluorescence intensity, resulted in the leakage of intracellular alkaline phosphatase (AKP) and ions, and caused a decline in ATP content and ATPase activity. Scanning electron microscopy (SEM) revealed significant membrane damage in each of the three bacterial species following juglone treatment. Transcriptomic sequencing and Gene Ontology (GO) enrichment analysis of S. pullorum revealed that juglone treatment resulted in a significant upregulation of GO terms related to translation, while those terms associated with transport, localization, and membrane functions were significantly downregulated. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that the pathways related to oxidative phosphorylation and the citrate cycle were significantly upregulated, whereas those pathways related to ABC transporters and quorum sensing were significantly downregulated.
conclusionThese findings suggest that juglone compromises the permeability and integrity of the cell envelope in E. coli, S. aureus, and S. pullorum, resulting in cytoplasmic leakage and metabolic impairment. Additionally, juglone alters the gene expression of transporters, interferes with the energy metabolism, protein synthesis and transport, quorum sensing, and biofilm formation of S. pullorum, thereby exerting antimicrobial effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.